133 related articles for article (PubMed ID: 36590169)
21. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
23. Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer.
Broekgaarden M; Anbil S; Bulin AL; Obaid G; Mai Z; Baglo Y; Rizvi I; Hasan T
Biomaterials; 2019 Nov; 222():119421. PubMed ID: 31494503
[TBL] [Abstract][Full Text] [Related]
24. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
25. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
26. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
[TBL] [Abstract][Full Text] [Related]
27. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
28. Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
Shinkawa T; Ohuchida K; Mochida Y; Sakihama K; Iwamoto C; Abe T; Ideno N; Mizuuchi Y; Shindo K; Ikenaga N; Moriyama T; Nakata K; Oda Y; Nakamura M
J Exp Clin Cancer Res; 2022 Mar; 41(1):89. PubMed ID: 35272688
[TBL] [Abstract][Full Text] [Related]
29. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
31. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
32. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
33. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
[TBL] [Abstract][Full Text] [Related]
34. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy.
Mukai Y; Yamada D; Eguchi H; Iwagami Y; Asaoka T; Noda T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2018 Jul; 25(7):1868-1879. PubMed ID: 29675761
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts are a useful cytological finding for diagnosing pancreatic ductal adenocarcinoma.
Saika T; Hirabayashi K; Itoh H; Miyajima Y; Serizawa A; Kato N; Oyamada H; Machida T; Kawanishi A; Nakamura N
Cytopathology; 2020 Jul; 31(4):310-314. PubMed ID: 32472717
[TBL] [Abstract][Full Text] [Related]
37. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation.
Wei L; Lin Q; Lu Y; Li G; Huang L; Fu Z; Chen R; Zhou Q
Cell Death Dis; 2021 Mar; 12(4):334. PubMed ID: 33782384
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
[TBL] [Abstract][Full Text] [Related]
40. Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model.
Schoonderwoerd MJA; Hakuno SK; Sassen M; Kuhlemaijer EB; Paauwe M; Slingerland M; Fransen MF; Hawinkels LJAC
Onco Targets Ther; 2021; 14():5205-5220. PubMed ID: 34744438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]